nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—ADRB2—chronic obstructive pulmonary disease	0.379	1	CbGaD
Nebivolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0982	0.18	CbGbCtD
Nebivolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0968	0.178	CbGbCtD
Nebivolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0745	0.137	CbGbCtD
Nebivolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0745	0.137	CbGbCtD
Nebivolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0733	0.135	CbGbCtD
Nebivolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0733	0.135	CbGbCtD
Nebivolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0187	0.0343	CbGbCtD
Nebivolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0187	0.0343	CbGbCtD
Nebivolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0166	0.0306	CbGbCtD
Nebivolol—Leukocytoclastic vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00178	0.0245	CcSEcCtD
Nebivolol—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.019	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.0161	CcSEcCtD
Nebivolol—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.000921	0.0126	CcSEcCtD
Nebivolol—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.0126	CcSEcCtD
Nebivolol—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.0113	CcSEcCtD
Nebivolol—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000774	0.0106	CcSEcCtD
Nebivolol—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000769	0.0106	CcSEcCtD
Nebivolol—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000703	0.00965	CcSEcCtD
Nebivolol—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000691	0.00948	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00065	0.00893	CcSEcCtD
Nebivolol—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000616	0.00845	CcSEcCtD
Nebivolol—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00061	0.00837	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00785	CcSEcCtD
Nebivolol—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00779	CcSEcCtD
Nebivolol—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00756	CcSEcCtD
Nebivolol—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00756	CcSEcCtD
Nebivolol—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.00751	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000542	0.00744	CcSEcCtD
Nebivolol—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000541	0.00743	CcSEcCtD
Nebivolol—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00714	CcSEcCtD
Nebivolol—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000513	0.00704	CcSEcCtD
Nebivolol—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.00684	CcSEcCtD
Nebivolol—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.00681	CcSEcCtD
Nebivolol—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000493	0.00676	CcSEcCtD
Nebivolol—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000493	0.00676	CcSEcCtD
Nebivolol—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00049	0.00672	CcSEcCtD
Nebivolol—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00049	0.00672	CcSEcCtD
Nebivolol—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000487	0.00668	CcSEcCtD
Nebivolol—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00664	CcSEcCtD
Nebivolol—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000463	0.00635	CcSEcCtD
Nebivolol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000451	0.00618	CcSEcCtD
Nebivolol—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000442	0.00607	CcSEcCtD
Nebivolol—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00606	CcSEcCtD
Nebivolol—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00606	CcSEcCtD
Nebivolol—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000434	0.00595	CcSEcCtD
Nebivolol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00043	0.00589	CcSEcCtD
Nebivolol—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00583	CcSEcCtD
Nebivolol—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00571	CcSEcCtD
Nebivolol—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00571	CcSEcCtD
Nebivolol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000415	0.0057	CcSEcCtD
Nebivolol—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00565	CcSEcCtD
Nebivolol—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.00565	CcSEcCtD
Nebivolol—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000411	0.00563	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00561	CcSEcCtD
Nebivolol—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00559	CcSEcCtD
Nebivolol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000399	0.00548	CcSEcCtD
Nebivolol—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000396	0.00543	CcSEcCtD
Nebivolol—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000396	0.00543	CcSEcCtD
Nebivolol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000393	0.0054	CcSEcCtD
Nebivolol—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00539	CcSEcCtD
Nebivolol—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00539	CcSEcCtD
Nebivolol—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00539	CcSEcCtD
Nebivolol—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00536	CcSEcCtD
Nebivolol—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00536	CcSEcCtD
Nebivolol—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00533	CcSEcCtD
Nebivolol—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00531	CcSEcCtD
Nebivolol—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00528	CcSEcCtD
Nebivolol—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00526	CcSEcCtD
Nebivolol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.0052	CcSEcCtD
Nebivolol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000373	0.00512	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000372	0.0051	CcSEcCtD
Nebivolol—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00509	CcSEcCtD
Nebivolol—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00506	CcSEcCtD
Nebivolol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.0049	CcSEcCtD
Nebivolol—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.0049	CcSEcCtD
Nebivolol—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000357	0.0049	CcSEcCtD
Nebivolol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00487	CcSEcCtD
Nebivolol—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000349	0.0048	CcSEcCtD
Nebivolol—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.0047	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.00468	CcSEcCtD
Nebivolol—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00462	CcSEcCtD
Nebivolol—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00456	CcSEcCtD
Nebivolol—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00456	CcSEcCtD
Nebivolol—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00456	CcSEcCtD
Nebivolol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00455	CcSEcCtD
Nebivolol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00454	CcSEcCtD
Nebivolol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00454	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00453	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00453	CcSEcCtD
Nebivolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00445	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00444	CcSEcCtD
Nebivolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00443	CcSEcCtD
Nebivolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00431	CcSEcCtD
Nebivolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.0043	CcSEcCtD
Nebivolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00429	CcSEcCtD
Nebivolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00429	CcSEcCtD
Nebivolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00428	CcSEcCtD
Nebivolol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00425	CcSEcCtD
Nebivolol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00425	CcSEcCtD
Nebivolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00423	CcSEcCtD
Nebivolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000306	0.0042	CcSEcCtD
Nebivolol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000306	0.00419	CcSEcCtD
Nebivolol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00416	CcSEcCtD
Nebivolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00406	CcSEcCtD
Nebivolol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00406	CcSEcCtD
Nebivolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00405	CcSEcCtD
Nebivolol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00401	CcSEcCtD
Nebivolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00399	CcSEcCtD
Nebivolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00395	CcSEcCtD
Nebivolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00395	CcSEcCtD
Nebivolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00393	CcSEcCtD
Nebivolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000284	0.0039	CcSEcCtD
Nebivolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.0039	CcSEcCtD
Nebivolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00389	CcSEcCtD
Nebivolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00389	CcSEcCtD
Nebivolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00387	CcSEcCtD
Nebivolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00028	0.00385	CcSEcCtD
Nebivolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.00383	CcSEcCtD
Nebivolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00381	CcSEcCtD
Nebivolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.0038	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00377	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00377	CcSEcCtD
Nebivolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00377	CcSEcCtD
Nebivolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00377	CcSEcCtD
Nebivolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00373	CcSEcCtD
Nebivolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00371	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.0037	CcSEcCtD
Nebivolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00369	CcSEcCtD
Nebivolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00368	CcSEcCtD
Nebivolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00367	CcSEcCtD
Nebivolol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00366	CcSEcCtD
Nebivolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00365	CcSEcCtD
Nebivolol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00364	CcSEcCtD
Nebivolol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00362	CcSEcCtD
Nebivolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00362	CcSEcCtD
Nebivolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.0036	CcSEcCtD
Nebivolol—ADRB1—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.000261	0.0658	CbGpPWpGaD
Nebivolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00358	CcSEcCtD
Nebivolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00358	CcSEcCtD
Nebivolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00358	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00356	CcSEcCtD
Nebivolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00356	CcSEcCtD
Nebivolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000255	0.0035	CcSEcCtD
Nebivolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00347	CcSEcCtD
Nebivolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00347	CcSEcCtD
Nebivolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00346	CcSEcCtD
Nebivolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00346	CcSEcCtD
Nebivolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00344	CcSEcCtD
Nebivolol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00342	CcSEcCtD
Nebivolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00341	CcSEcCtD
Nebivolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00341	CcSEcCtD
Nebivolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000248	0.0034	CcSEcCtD
Nebivolol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00339	CcSEcCtD
Nebivolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00339	CcSEcCtD
Nebivolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00339	CcSEcCtD
Nebivolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00338	CcSEcCtD
Nebivolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00328	CcSEcCtD
Nebivolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00326	CcSEcCtD
Nebivolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00322	CcSEcCtD
Nebivolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00322	CcSEcCtD
Nebivolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000235	0.00322	CcSEcCtD
Nebivolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00316	CcSEcCtD
Nebivolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00314	CcSEcCtD
Nebivolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00314	CcSEcCtD
Nebivolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00309	CcSEcCtD
Nebivolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00309	CcSEcCtD
Nebivolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00307	CcSEcCtD
Nebivolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00304	CcSEcCtD
Nebivolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00303	CcSEcCtD
Nebivolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00299	CcSEcCtD
Nebivolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00299	CcSEcCtD
Nebivolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00296	CcSEcCtD
Nebivolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00293	CcSEcCtD
Nebivolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00292	CcSEcCtD
Nebivolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00289	CcSEcCtD
Nebivolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00289	CcSEcCtD
Nebivolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00283	CcSEcCtD
Nebivolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00282	CcSEcCtD
Nebivolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00279	CcSEcCtD
Nebivolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00278	CcSEcCtD
Nebivolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00278	CcSEcCtD
Nebivolol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00276	CcSEcCtD
Nebivolol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00276	CcSEcCtD
Nebivolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00275	CcSEcCtD
Nebivolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00275	CcSEcCtD
Nebivolol—Headache—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00274	CcSEcCtD
Nebivolol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00274	CcSEcCtD
Nebivolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00273	CcSEcCtD
Nebivolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00272	CcSEcCtD
Nebivolol—Rash—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0027	CcSEcCtD
Nebivolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0027	CcSEcCtD
Nebivolol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00268	CcSEcCtD
Nebivolol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00266	CcSEcCtD
Nebivolol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000193	0.00265	CcSEcCtD
Nebivolol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00264	CcSEcCtD
Nebivolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00263	CcSEcCtD
Nebivolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00261	CcSEcCtD
Nebivolol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0026	CcSEcCtD
Nebivolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.0026	CcSEcCtD
Nebivolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0026	CcSEcCtD
Nebivolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.0026	CcSEcCtD
Nebivolol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000189	0.0026	CcSEcCtD
Nebivolol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00259	CcSEcCtD
Nebivolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00255	CcSEcCtD
Nebivolol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00254	CcSEcCtD
Nebivolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00247	CcSEcCtD
Nebivolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00245	CcSEcCtD
Nebivolol—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00233	CcSEcCtD
Nebivolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00214	CcSEcCtD
Nebivolol—HTR1A—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	0.000155	0.0391	CbGpPWpGaD
Nebivolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Nebivolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00212	CcSEcCtD
Nebivolol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00211	CcSEcCtD
Nebivolol—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00193	CcSEcCtD
Nebivolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00189	CcSEcCtD
Nebivolol—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00189	CcSEcCtD
Nebivolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00188	CcSEcCtD
Nebivolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00185	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00178	CcSEcCtD
Nebivolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00174	CcSEcCtD
Nebivolol—Shock—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00169	CcSEcCtD
Nebivolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00169	CcSEcCtD
Nebivolol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00167	CcSEcCtD
Nebivolol—ADRB1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0297	CbGpPWpGaD
Nebivolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00157	CcSEcCtD
Nebivolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00156	CcSEcCtD
Nebivolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00155	CcSEcCtD
Nebivolol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00149	CcSEcCtD
Nebivolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00149	CcSEcCtD
Nebivolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00148	CcSEcCtD
Nebivolol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00148	CcSEcCtD
Nebivolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00141	CcSEcCtD
Nebivolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00141	CcSEcCtD
Nebivolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.00137	CcSEcCtD
Nebivolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.00136	CcSEcCtD
Nebivolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	9.32e-05	0.0234	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	9.25e-05	0.0233	CbGpPWpGaD
Nebivolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.00127	CcSEcCtD
Nebivolol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	9.16e-05	0.0231	CbGpPWpGaD
Nebivolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	9e-05	0.00123	CcSEcCtD
Nebivolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.00122	CcSEcCtD
Nebivolol—HTR1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	8.85e-05	0.0223	CbGpPWpGaD
Nebivolol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	8.59e-05	0.0216	CbGpPWpGaD
Nebivolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.00118	CcSEcCtD
Nebivolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.00114	CcSEcCtD
Nebivolol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	8.26e-05	0.0208	CbGpPWpGaD
Nebivolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.00109	CcSEcCtD
Nebivolol—Rash—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.00108	CcSEcCtD
Nebivolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.00108	CcSEcCtD
Nebivolol—Headache—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.00108	CcSEcCtD
Nebivolol—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	7.79e-05	0.0196	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	7.77e-05	0.0196	CbGpPWpGaD
Nebivolol—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	7.5e-05	0.0189	CbGpPWpGaD
Nebivolol—Nausea—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.00102	CcSEcCtD
Nebivolol—HTR1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	7.44e-05	0.0187	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	7.23e-05	0.0182	CbGpPWpGaD
Nebivolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	7.07e-05	0.0178	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	6.92e-05	0.0174	CbGpPWpGaD
Nebivolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	6.77e-05	0.017	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	6.41e-05	0.0161	CbGpPWpGaD
Nebivolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	6.34e-05	0.016	CbGpPWpGaD
Nebivolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	6.2e-05	0.0156	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	6.08e-05	0.0153	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	5.94e-05	0.015	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	5.81e-05	0.0146	CbGpPWpGaD
Nebivolol—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	5.79e-05	0.0146	CbGpPWpGaD
Nebivolol—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	5.66e-05	0.0143	CbGpPWpGaD
Nebivolol—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.45e-05	0.0137	CbGpPWpGaD
Nebivolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	5.04e-05	0.0127	CbGpPWpGaD
Nebivolol—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	4.49e-05	0.0113	CbGpPWpGaD
Nebivolol—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.0106	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	3.6e-05	0.00907	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.31e-05	0.00833	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	3.25e-05	0.00819	CbGpPWpGaD
Nebivolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.24e-05	0.00814	CbGpPWpGaD
Nebivolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	3.21e-05	0.00807	CbGpPWpGaD
Nebivolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.19e-05	0.00804	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	3.14e-05	0.00791	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	3.05e-05	0.00767	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	2.93e-05	0.00738	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.84e-05	0.00716	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.78e-05	0.007	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	2.77e-05	0.00697	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.72e-05	0.00685	CbGpPWpGaD
Nebivolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.62e-05	0.0066	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.44e-05	0.00613	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.38e-05	0.006	CbGpPWpGaD
Nebivolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.00592	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.33e-05	0.00587	CbGpPWpGaD
Nebivolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.32e-05	0.00584	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	2.26e-05	0.00568	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	2e-05	0.00502	CbGpPWpGaD
Nebivolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.91e-05	0.0048	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.86e-05	0.00467	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.82e-05	0.00457	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.78e-05	0.00449	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.78e-05	0.00447	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.71e-05	0.0043	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.00422	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.00417	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.53e-05	0.00385	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.52e-05	0.00383	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.49e-05	0.00374	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.00368	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.45e-05	0.00366	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.4e-05	0.00351	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.00351	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.00346	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.00344	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.00343	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.00336	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.00336	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.00329	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.3e-05	0.00327	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.27e-05	0.0032	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.24e-05	0.00313	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.23e-05	0.0031	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.00301	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.18e-05	0.00298	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.18e-05	0.00297	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.00294	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.00293	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.00293	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.16e-05	0.00291	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.00288	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.00288	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.13e-05	0.00284	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.11e-05	0.0028	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.00269	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.00265	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.05e-05	0.00264	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.00262	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.03e-05	0.00258	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.02e-05	0.00256	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.00255	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1e-05	0.00252	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1e-05	0.00252	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.99e-06	0.00251	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.95e-06	0.0025	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.53e-06	0.0024	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.32e-06	0.00234	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.21e-06	0.00232	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.11e-06	0.00229	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.1e-06	0.00229	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.01e-06	0.00227	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.9e-06	0.00224	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	8.88e-06	0.00224	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.81e-06	0.00222	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.71e-06	0.00219	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.58e-06	0.00216	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	8.15e-06	0.00205	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.38e-06	0.00186	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.22e-06	0.00182	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.06e-06	0.00178	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.98e-06	0.00176	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.93e-06	0.00174	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.83e-06	0.00172	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.68e-06	0.00168	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.58e-06	0.00166	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.29e-06	0.00158	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.98e-06	0.0015	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.88e-06	0.00148	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.75e-06	0.00145	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.72e-06	0.00144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.63e-06	0.00142	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.62e-06	0.00142	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.62e-06	0.00142	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.5e-06	0.00139	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.5e-06	0.00138	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.4e-06	0.00136	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.38e-06	0.00135	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.38e-06	0.00135	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.34e-06	0.00134	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.25e-06	0.00132	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.22e-06	0.00131	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.14e-06	0.00129	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.11e-06	0.00129	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.03e-06	0.00127	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.92e-06	0.00124	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.88e-06	0.00123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.67e-06	0.00118	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.57e-06	0.00115	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.47e-06	0.00112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.11e-06	0.00104	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.02e-06	0.00101	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.94e-06	0.00099	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.82e-06	0.000963	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.74e-06	0.000942	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.66e-06	0.000921	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.53e-06	0.000888	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.38e-06	0.00085	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.18e-06	0.0008	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.15e-06	0.000794	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.11e-06	0.000782	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.09e-06	0.000777	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.04e-06	0.000765	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.02e-06	0.000759	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.89e-06	0.000726	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.87e-06	0.000722	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.87e-06	0.000722	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.83e-06	0.000713	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.82e-06	0.00071	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.8e-06	0.000706	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.76e-06	0.000695	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.76e-06	0.000694	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.74e-06	0.00069	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.7e-06	0.000679	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.64e-06	0.000664	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.59e-06	0.000651	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.57e-06	0.000646	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.51e-06	0.000632	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.45e-06	0.000618	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.38e-06	0.0006	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.11e-06	0.000531	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.06e-06	0.000519	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.02e-06	0.000508	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.01e-06	0.000507	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-06	0.0005	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.97e-06	0.000496	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-06	0.000493	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.93e-06	0.000485	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.92e-06	0.000484	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.88e-06	0.000473	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.84e-06	0.000463	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-06	0.00046	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-06	0.000436	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.7e-06	0.000429	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.67e-06	0.00042	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.63e-06	0.00041	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.62e-06	0.000408	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.59e-06	0.000399	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.55e-06	0.00039	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.54e-06	0.000388	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.51e-06	0.00038	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.47e-06	0.000371	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.38e-06	0.000348	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.35e-06	0.000341	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.32e-06	0.000333	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.27e-06	0.00032	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-06	0.000314	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.24e-06	0.000313	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.22e-06	0.000307	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.22e-06	0.000306	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.19e-06	0.0003	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-06	0.000296	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-06	0.000283	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-06	0.000263	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.02e-06	0.000258	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1e-06	0.000252	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.58e-07	0.000241	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.37e-07	0.000236	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.16e-07	0.000231	CbGpPWpGaD
